FDA Approves Actemra for CAR T Cell-Induced CRS – PharmaLive (press release) (subscription)
|
FDA Approves Actemra for CAR T Cell-Induced CRS
PharmaLive (press release) (subscription) “Until today, there has never been an FDA-approved treatment to manage severe cytokine release syndrome associated with CAR T cell therapy, which is marked by a rapid onset and can cause life-threatening complications,” said Sandra Horning, M.D., chief … |
